OVERVIEW ·     TRACK
RECORD		 ·     BENEFITS ·     FAQs  ·    WHAT'S NEXT ·      HOW WE
PICK STOCKS		 ·       SUBSCRIBE ·      PENNYSTOCKSTM
NEWSLETTER  

Forbes Directory - Best of the Web
Best of the Web
(Small Caps)
Barron's > read review
As Featured:
*BARRON's
*CNNfn.com
*BusinessWeek Online
*Wired News
*C/NET
*Barron's Electronic
Edition

*Home
*Links
*Sitemap

Track Record 1997

1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013



Our covered positions for the Newsletter Portfolio are below.
70% have been for GAINS of 50% or GREATER.


CEMEX. Closed on 2/28/97 at $8.75 for a 226% GAIN.

MESA. Closed on 2/28/97 at $6.38 for a 62% GAIN.

TELEFONICA DEL PERU. Closed on 2/28/97 at $23.25 for a 16% GAIN.
(Recommended at $2 before the reverse split).

QUESTEC IMAGING. Closed on 2/28/97 at 60¢ for a 48% LOSS.

GANDALF TECHNOLOGIES Closed on 5/13/97 at $2.25 for a 120% GAIN

ALDILA Closed on 5/15/97 at $4.56 for a BREAKEVEN

AMERICAN BANKNOTE Closed on 9/29/97 at $6.38 for a 82% GAIN

LAIDLAW ENVIRONMENTAL Closed on 9/29/97 at $5.12 for a 84% GAIN

RDM SPORTS Closed on 9/29/97 at $0.00 for a 100% LOSS

IPL SYSTEMS Closed on 9/29/97 at $2.50 for a 81% GAIN

ITEX CORPORATION Closed on 10/15/97 at $6.25 for a 92% GAIN

ANDYNE COMPUTING Closed on 10/23/97 at $8.12 for a 62% GAIN

PDG ENVIRONMENTAL Closed on 11/10/97 at $1.59 for a 112% GAIN


Some of our other recommendations, featured in The Newsletter, include:

  • A China play capitalizing of the country's liquid petroleum gas market.
    EXCHANGE: OTCBB RECOMMENDED PRICE: 29¢ TARGET: 75¢ - $1.00

  • A provider of in-home patient care.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.50 TARGET: $6.50 - $7.00

  • An energy company that could be sitting on top of an "Elephant Field" in Columbia.
    EXCHANGE: AMEX RECOMMENDED PRICE: $4.75 TARGET: $10

  • A gold producer claiming to have 1.8 million ounces of proven reserves in Chile.
    EXCHANGE: NYSE RECOMMENDED PRICE: $4.50 TARGET: $7.00 - $8.00

  • An energy company that has increased revenues by 60%.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.81 TARGET: $4.25 - $5.50

  • A biotech company that has grown despite adversity.
    EXCHANGE: OTCBB RECOMMENDED PRICE: 88¢ TARGET: $1.75 - $2.25

  • A high-tech company poised for a turnaround.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.00 TARGET: $5.00 - $7.00

  • A manufacturer of plastics products and storage tanks that has had favorable insider activity, and pays a dividend.
    EXCHANGE: AMEX RECOMMENDED PRICE: $1.50 TARGET: $2.25 - $2.75

  • A 185 store franchised restaurant chain featuring low-cost food items.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: 72¢ TARGET: $1.25 - $1.50

  • A U.S. gold play that will need a little investor patience.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: 93¢ TARGET: $1.75 - $2.25

  • A developer and marketer of environmental sensor equipment.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: 31¢ TARGET: 75¢ - $1.00

  • A Canadian diamond mining company that is in a joint venture with De Beers.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.18 TARGET: $5.50 - $6.50

  • The leading provider of alternate site infusion therapy in the U.S.
    EXCHANGE: NYSE RECOMMENDED PRICE: $3.18 TARGET: $8.50 - $11.00

  • A developmental-stage biotech with some very promising oral tolerance drugs.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.75 TARGET: $7.50 - $9.00

  • A medical equipment maker recently included in The Wired Interactice.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.81 TARGET: $9.00 - $11.00

  • A leading provider of blood products and services.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: 75¢ TARGET: $1.60 - $2.00

  • A software provider with a customer base of 2000 blue chip clients.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $3.12 TARGET: $8.50 - $10.00

  • A biotech that is in late-stage trials on a treatment for lymph cancer.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.38 TARGET: $6.50 - $7.00

  • The largest HMO in New York State's Hudson River Valley.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.00 TARGET: $5.50 - $6.50

  • A biotech that markets diagnostic imaging agents for the colorectal and ovarian cancers.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.12 TARGET: $7.00 - $7.50

  • A software developer of products that allows PC users to communicate across diverse networking environments.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.50 TARGET: $6.00 - $7.00

  • A hitech whose broad product line, based on ATM technology, addresses some of the fastest growing networking areas.
    EXCHANGE: NYSE RECOMMENDED PRICE: $4.12 TARGET: $8.50 - $10.00

  • A helthcare management company that owns or manages five HMO's.
    EXCHANGE: NYSE RECOMMENDED PRICE: $2.62 TARGET: $5.75 - $6.50

  • A hi-tech that makes and distributes digital equipment and software used in television production.
    EXCHANGE: NYSE RECOMMENDED PRICE: $3.88 TARGET: $8.50 - $9.50

  • A company that has bugs soak up the sulphur in crude oil and petroleum products.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.38 TARGET: $5.00 - $6.50

  • A wireless telecomm that portends to be a wild ride.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $1.31 TARGET: $2.75 - $3.00

  • A video rental company that looks as if it could be making a comeback.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $2.75 TARGET: $4.75 - $5.00

  • A gaming company that looks as if it could again become the high flier it once was.
    EXCHANGE: NASDAQ RECOMMENDED PRICE: $4.38 TARGET: $9.00 - $10.00

  • A leading provider of hitech solutions designed to improve productivity in the workplace.
    EXCHANGE: OTCBB RECOMMENDED PRICE: $2.00 TARGET: $4.00 - $5.00

  • A Canadian gold producer that not only is expanding its operations, but is still making money.
    EXCHANGE: AMEX RECOMMENDED PRICE: $2.75 TARGET: $5.50 - $7.00


    The Newsletter is published twice-monthly. Upon receipt of your subscription, we will e-mail a password, and further information, to you. Good Luck.



    • Copyright ®1996-2013 Global Penny Stocks®
    Site created by Princeton Internet Group, Inc. (PING)
    Privacy Policy and Disclaimer